COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 957: Articles 9561-9570  | Next

Cardiopulmonary imaging utilization and findings among hospitalized COVID-19 patients in Latin America (From RIMAC: Registry IMAging Cardiopulmonary among hospitalized COVID-19 patients in LATAM)
Spina, S. V., Campos Vieira, M. L., Herrera, C., Munera Echeverri, A., Rojo, P., Arrioja Salazar, A. S., Vazquez Ortiz, Z., Baltodano, R., Reyes, G., Aceves Millan, R., Calderon Gonzalez, J., Camarozano, A., Aviles, E., Cabrera, M. A., Grande Ratti, M. F., Lowenstein, J., Hernandez Vyhmeister, R., Pina Santana, P., Ibarra Burgos, J., Rivera, A., Fernandez Campos, B., Cupe Chacalcaje, K., De Santos, M., Afonso, T. R., Miranda Aquino, T., Lalyre Acosta, A., Dominguez, B., Campos, F., Alday Ramirez, S., Cachicatari Beltran, A., Alvarez, D., Oliveira Roveri, P., Rosales Ixcamparij, C., Otoniel Gonzalez, E., Vargas, P., Flores Flamand, M., Lopez Martinez, R., Meza, L., Saady Morthy, S., Ovalle, R., Martinez, S., Perez Orpinel, O., Potito, M., Orellana, O., Marte Baez, J., Orihuela Sandoval, C., Granillo Fernandez, M., Loomba, R., Flores, S., Hernandez Hernandez, J. M., Pignatelli, R.
10.1101/2022.01.10.22269002 — Posted: 2022-01-11
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis
Madewell, Z. J., Yang, Y., Longini, I. M., Halloran, M. E., Dean, N. E.
10.1101/2022.01.09.22268984 — Posted: 2022-01-11
General anxiety and depression are associated with the physical activity and social interaction levels: Study in Argentinean university students during the COVID-19 outbreak
Barbuzza, A., Benedetti, P., Goyeneche, C., Reppucci, V., Moscato, F., Ramirez Butavand, D., Katche, C., Medina, J. H., Moncada, D., Viola, H., Ballarini, F.
10.1101/2022.01.07.22268803 — Posted: 2022-01-11
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California
Lewnard, J. A., Hong, V. X., Patel, M. M., Kahn, R., Lipsitch, M., Tartof, S. Y.
10.1101/2022.01.11.22269045 — Posted: 2022-01-11 Discussion: Onsite
Two viruses competition in the SIR model of epidemic spread: application to COVID-19
Trigger, S. A., Ignatov, A. M.
10.1101/2022.01.11.22269046 — Posted: 2022-01-11
Granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies treatment for COVID-19 patients: a meta-analysis
Guan, J., Xi, A., Jin, D., Mou, X., Xu, Z.
10.1101/2022.01.07.22268878 — Posted: 2022-01-10
Identifying SARS-CoV-2 regional introductions and transmission clusters in real time
McBroome, J., Martin, J., de Bernardi Schneider, A., Turakhia, Y., Corbett-Detig, R.
10.1101/2022.01.07.22268918 — Posted: 2022-01-10
Strong SARS-CoV-2 N-specific CD8+ T immunity induced by engineered extracellular vesicles associates with protection from lethal infection in mice.
Ferrantelli, F., Chiozzini, C., Manfredi, F., Leone, P., Spada, M., DiVirgilio, A., Giovannelli, A., Sanchez, M., Cara, A., Michelini, Z., Federico, M.
10.1101/2022.01.10.475620 — Posted: 2022-01-10
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Saunders, N., Planas, D., Bolland, W. H., Rodriguez, C., Fourati, S., Buchrieser, J., Planchais, C., Prot, M., Staropoli, I., Guivel-Benhassine, F., Porrot, F., Veyer, D., Pere, H., Robillard, N., Saliba, M., Baidaliuk, A., Seve, A., Hocqueloux, L., Prazuck, T., Mouquet, H., Simon-Loriere, E., Bruel, T., Pawlotsky, J.-M., Schwartz, O.
10.1101/2022.01.07.475248 — Posted: 2022-01-10
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
Jonsdottir, H. R., Siegrist, D., Julien, T., Padey, B., Bouveret, M., Terrier, O., Pizzorno, A., Huang, S., Samby, K., Wells, T., Boda, B., Rosa-Calatrava, M., Engler, O., Constant, S.
10.1101/2022.01.10.475377 — Posted: 2022-01-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).